BRIEF published on 11/01/2024 at 17:05, 1 year 1 month ago KBKG Announces Key Leadership Changes Leadership Changes KBKG Tax Services Jason Melillo Gian Pazzia
PRESS RELEASE published on 11/01/2024 at 17:00, 1 year 1 month ago KBKG Announces Leadership Changes KBKG appoints Jason Melillo as CEO and Gian Pazzia as Chairman & Chief Strategy Officer, effective Nov. 1, 2024. Melillo to lead Employment Tax Incentives practice CEO KBKG Jason Melillo Gian Pazzia Tax Incentives
BRIEF published on 04/29/2024 at 14:05, 1 year 7 months ago KBKG Launches Dash.tax to Simplify R&D Tax Credit Claims for Small Businesses and CPAs KBKG Dash.tax R&D Tax Credit Small Business Tax Software
PRESS RELEASE published on 04/29/2024 at 14:00, 1 year 7 months ago Simple, Swift, Secure: KBKG's Dash.tax Transforms R&D Tax Credits Up to $50k KBKG introduces Dash.tax, a new R&D tax credit software for CPAs and businesses. It simplifies claiming credits up to $50,000 with instant reports, intuitive UI, robust security & white-labeling options Businesses KBKG Dash.tax R&D Tax Credit CPAs
Published on 12/05/2025 at 02:35, 3 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 38 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 43 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 58 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 8 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
